Consensus Globus Medical, Inc.

Equities

GMED

US3795772082

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
53.64 USD +1.09% Intraday chart for Globus Medical, Inc. +2.90% +0.66%

Evolution of the average Target Price on Globus Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

32ed429c361.qpB_FvD42ncwaCJ-jHP2qAMm_qEm1PewbU88bYZPlZg.nPQQcsOSlBhmKkA9_CmuxUYWl5AUpJHiPwh4XOsY2u7a1DlfvoiyGgUQaw~cea8568a3c0a24f6da14ee0ed7b0bd71
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating MT
Investors keep their cool despite inflation data Our Logo
Truist Adjusts Price Target on Globus Medical to $58 From $53, Maintains Hold Rating MT
Canaccord Genuity Adjusts Globus Medical's Price Target to $71 From $67, Keeps Buy Rating MT
RBC Cuts Price Target on Globus Medical to $70 From $77, Keeps Outperform Rating MT
Morgan Stanley Cuts Price Target on Globus Medical to $53 From $60, Maintains Equalweight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $53 From $58, Maintains Hold Rating MT
Roth MKM Starts Globus Medical With Buy Rating, Price Target is $75 MT
Stifel Upgrades Globus Medical to Buy From Hold, Cuts Price Target to $61 From $65 MT
Wells Fargo Lowers Price Target on Globus Medical to $58 From $63, Maintains Equal-Weight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $65 From $68, Keeps Hold Rating MT
Barclays Raises Price Target on Globus Medical to $77 From $75, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $68 From $64, Maintains Hold Rating MT
Morgan Stanley Adjusts Globus Medical's Price Target to $60 From $64, Keeps Equalweight Rating MT
Truist Securities Adjusts Globus Medical Price Target to $64 From $66, Maintains Hold Rating MT
Canaccord Genuity Upgrades Globus Medical to Buy From Hold With $67 Price Target MT
Morgan Stanley Adjusts Globus Medical Price Target to $64 From $78, Maintains Equal Weight Rating MT
Wells Fargo Adjusts Price Target on Globus Medical to $61 From $67, Maintains Equalweight Rating MT
Canaccord Genuity Adjusts Price Target on Globus Medical to $67 From $75, Maintains Hold Rating MT
BofA Securities Downgrades Globus Medical to Underperform From Buy, Adjusts Price Target to $63 From $83 MT
RBC Cuts Price Target on Globus Medical to $77 From $85, Citing Deal Valuation, Maintains Outperform Rating MT
Truist Downgrades Globus Medical to Hold From Buy, Price Target is $70 MT
Loop Capital Downgrades Globus Medical to Hold From Buy, Adjusts Price Target to $70 From $90 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
53.64 USD
Average target price
65.31 USD
Spread / Average Target
+21.75%
High Price Target
83 USD
Spread / Highest target
+54.74%
Low Price Target
55 USD
Spread / Lowest Target
+2.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Globus Medical, Inc.

BTIG
Truist Securities
Stifel Nicolaus
Canaccord Genuity
RBC Capital Markets
Morgan Stanley
Roth MKM
Wells Fargo Securities
Barclays
BofA Securities
Loop Capital
Needham & Co.
Piper Sandler
Jefferies & Co.
Oppenheimer
UBS
Credit Suisse
Citigroup
SVB Leerink
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings